[1]康盈盈,朱丽娟,王文节,等.垂体影像学特征在无功能性垂体腺瘤术后内分泌功能评估中的作用[J].中国临床神经外科杂志,2022,27(06):440-443446.[doi:10.13798/j.issn.1009-153X.2022.06.003]
 KANG Ying-ying,ZHU Li-juan,WANG Wen-jie,et al.Application of MRI features of pituitary to prediction of the endocrine function of patients with nonfunctional pituitary adenoma after endoscopic transsphenoidal surgery[J].,2022,27(06):440-443446.[doi:10.13798/j.issn.1009-153X.2022.06.003]
点击复制

垂体影像学特征在无功能性垂体腺瘤术后内分泌功能评估中的作用()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
27
期数:
2022年06期
页码:
440-443446
栏目:
论著
出版日期:
2022-06-30

文章信息/Info

Title:
Application of MRI features of pituitary to prediction of the endocrine function of patients with nonfunctional pituitary adenoma after endoscopic transsphenoidal surgery
文章编号:
1009-153X(2022)06-0440-04
作者:
康盈盈朱丽娟王文节孙剑瑞
450052 郑州,郑州大学第一附属医院神经外科(康盈盈、朱丽娟、王文节、孙剑瑞)
Author(s):
KANG Ying-ying ZHU Li-juan WANG Wen-jie SUN Jian-rui
Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
关键词:
无功能垂体腺瘤经鼻蝶入路神经内镜手术MRI特征垂体内分泌功能
Keywords:
Nonfunctional pituitary adenoma Endoscopic transsphenoidal surgery MRI feature Endocrine function
分类号:
R739.41;R651.1+1
DOI:
10.13798/j.issn.1009-153X.2022.06.003
文献标志码:
A
摘要:
目的 探讨垂体影像学特征在无功能性垂体腺瘤(NFPA)术后内分泌功能评估中的作用。方法 回顾性分析2010年3月~2021年3月经鼻蝶入路神经内镜手术切除的96例NFPA的临床资料。术前、术后2个月、术后12个月评估激素功能。结果 术前54例(56.3%)出现垂体功能减退,术后2、12个月分别有67例(69.8%)和55例(57.3%)存在垂体功能减退。与术前相比,术后2、12个月,性腺功能减退、甲状腺功能减退、生长激素缺乏无明显变化(P>0.05),高泌乳素血症明显减少(P<0.05),但是肾上腺皮质功能减退、尿崩症术后2个月明显增加(P<0.05)、术后12个月又明显减少(P<0.05)。19例(19.8%)术后12个月出现少一个激素轴功能恶化。单因素分析显示,术前垂体柄是否可见与术后垂体功能恶化无明显关系(P>0.05),术前垂体腺可见程度、肿瘤切除程度、肿瘤体积与术后激素恶化有关(P<0.05)。多因素logistic回归分析显示术前垂体腺不可见是术后激素恶化的独立影响因素(P<0.05)。结论 垂体功能减退是NFPA常见的临床表现,术前垂体功能评估具有重要意义。术后垂体激素轴可能恶化,垂体影像学特征,例如垂体腺可见程度、肿瘤大小等,可作为术后垂体功能恶化的评估指标。
Abstract:
Objective To investigate the value of pituitary imaging features in the assessment of endocrine function of the patients with nonfunctional pituitary adenoma (NFPA) after endoscopic transsphenoidal surgery (ETS). Methods The clinical data of 96 patients with NFPA who underwent ETS from March 2010 to March 2021 were retrospectively analyzed. Endocrine function was assessed before surgery, 2 months and 12 months after surgery. Results Hypopituitarism occurred in 54 patients (56.3%) before operation, and in 67 patients (69.8%) and 55 patients (57.3%) 2 and 12 months after operation, respectively. Compared with before operation, there were no significant changes in hypogonadism, hypothyroidism, and growth hormone deficiency 2 and 12 months after operation (P>0.05), and hyperprolactinemia was significantly reduced (P<0.05). Hypoadrenocorticism and diabetes insipidus increased significantly 2 months after operation (P<0.05), and decreased significantly 12 months after operation (P<0.05). Endocrine function deterioration, with one less hormonal axis functional deterioration 12 months after surgery, occurred in 19 patients (19.8%). Univariate analysis showed that preoperative pituitary gland visibility, tumor resection, and tumor volume were associated with postoperative hormonal deterioration (P<0.05), but the visibility of the pituitary stalk was not significantly related to the deterioration of pituitary function after surgery (P>0.05). Multivariate logistic regression analysis showed that absence of pituitary gland on preoperative MRI was an independent risk factor for postoperative hormonal deterioration (P<0.05). Conclusions Hypopituitarism is a common clinical manifestation of patients with NFPA, and preoperative assessment of pituitary function is of great significance. The pituitary hormone axis may deteriorate after NFPA. Preoperative pituitary imaging features, such as the visibility of the pituitary gland and tumor size, can be used as evaluation indicators for the deterioration of pituitary function after surgery.

参考文献/References:

[1] Ntali G, Wass JA. Epidemiology, clinical presentation anddiagnosis of non-functioning pituitary adenomas [J]. Pituitary, 2018, 21(2): 111-118.
[2] Wang SS, Li B, Ding CY, et al. A novel "total pituitary hormone index" as an indicator of postoperative pituitary function inpatients undergoing resection of pituitary adenomas[J]. Oncotarget, 2017, 8(45): 79111-79125.
[3] 李一君,谷伟军,王岳鹏,等. 4276例垂体瘤的回顾性临床分析[J]. 国际内分泌代谢杂志,2022,42(1):7-11.
[4] 赵 鹏,刘志远,许 可,等. 垂体腺瘤神经外科临床路径[J]. 中国肿瘤外科杂志,2022,14(1):16-21.
[5] 杨 强,杨 虎,贾艳飞,等. 神经内镜经鼻蝶入路切除垂体腺瘤术后复发的影响因素及其预测价值[J]. 中华神经外科杂志,2021,37(9):928-932.
[6] Esposito D, Olsson DS, Ragnarsson O, et al. Non-functioning pituitary adenomas: indications for pituitary surgery and postsurgical management [J]. Pituitary, 2019, 22(4): 422-434.
[7] Kim JH, Lee JH, Lee JH, et al. Endoscopic transsphenoidal surgery outcomes in 331 nonfunctioning pituitary adenoma cases after a single surgeon learning curve [J]. World
Neurosurg, 2018, 109: e409-e416.
[8] 中华医学会内分泌学分会. 成人生长激素缺乏症诊治专家共识(2020版)[J]. 中华内分泌代谢杂志,2020,36(12):995-1002.
[9] 郑鹏杰,张少玲. 肾上腺皮质功能减退症的诊治现状[J]. 内科急危重症杂志,2019,25(1):73-79.
[10] Araujo-Castro M, Acitores Cancela A, Vior C, et al. Radio-logical Knosp, Revised-Knosp, and Hardy-Wilson Classi-fications for the prediction of surgical outcomes in the
endoscopic endonasal surgery of pituitary adenomas: study of 228 cases [J]. Front Oncol, 2022, 11: 807040.
[11] 付晓红,薛鑫诚,周培志,等. 垂体瘤术后垂体功能变化及激素替代[J]. 四川大学学报(医学版),2013,44:448-451.
[12] Jahangiri A, Wagner JR, Han SW, et al. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis [J]. J Neurosurg, 2016, 124(3): 589-595.
[13] Wang F, Zhang J, Wang P, et al. Prediction of pituitary stalk position in pituitary adenomas by visualization of the hypothalamo-hypophyseal tract using diffusion tensor imaging tractography [J]. Medicine (Baltimore), 2018, 97(10): e0052.
[14] Castle-Kirszbaum M, Wang YY, King J, et al. Predictors of visual and endocrine outcomes after endoscopic trans-sphenoidal surgery for pituitary adenomas [J]. Neurosurg Rev, 2022, 45(1): 843-853.

相似文献/References:

[1]王亚平 贾晓雄 王 珺 王林林 谭溢涛 马德得 夏鹤春.神经内镜下与显微镜下经鼻蝶入路手术切除垂体腺瘤的疗效对比分析[J].中国临床神经外科杂志,2016,(03):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
 WANG Ya-ping,JIA Xiao-xiong,WANG-Jun,et al.Resection of pituitary adenomas by endoscopic and microscopic surgery via transnasal transsphenoidal approach: a comparative analysis[J].,2016,(06):145.[doi:10.13798/j.issn.1009-153X.2016.03.004]
[2]线春明 张 强 杨 鹏.垂体脓肿的诊治分析:附3例报告并文献复习[J].中国临床神经外科杂志,2016,(01):38.[doi:10.13798/j.issn.1009-153X.2016.01.013]
[3]甘志强 龚 杰 姚国杰 张 戈 黄 成 秦 汉 陈大瑜 马廉亭.PACS系统影像测量在经鼻蝶入路手术治疗鞍区病变中的价值[J].中国临床神经外科杂志,2015,(08):463.[doi:10.13798/j.issn.1009-153X.2015.08.006]
 GAN Zhi-qiang,GONG Jie,YAO Guo-jie,et al.Value of measuring the anatomic markers related to operation with PACS software to transsphenoidal surgery for sellar lesions[J].,2015,(06):463.[doi:10.13798/j.issn.1009-153X.2015.08.006]
[4]王 璨 喻军华 黄锦峰 陈志勇 刘 斌 袁学刚 吴新宇.经鼻蝶入路显微手术切除垂体腺瘤36例[J].中国临床神经外科杂志,2015,(09):547.[doi:10.13798/j.issn.1009-153X.2015.09.012]
[5]苏卢海 张世渊 胡昌辰 沈 波.神经导航辅助内镜下经鼻蝶入路手术治疗垂体腺瘤的疗效观察[J].中国临床神经外科杂志,2015,(09):549.[doi:10.13798/j.issn.1009-153X.2015.09.013]
[6]王重韧 赵 明 徐 欣 尤 宇 韩 磊 赵四军.症状型Rathke裂隙囊肿的临床特征及外科治疗(附13例报告)[J].中国临床神经外科杂志,2015,(04):214.[doi:10.13798/j.issn.1009-153X.2015.04.007]
 WANG Chong-ren,ZHAO Ming,XU Xin,et al.Clinical features and surgical treatment of symptomatic Rathke cleft cysts (report of 13 cases)[J].,2015,(06):214.[doi:10.13798/j.issn.1009-153X.2015.04.007]
[7]赵建平,张红波,穆林森,等.内镜下经鼻蝶术后迟发性鼻出血的护理[J].中国临床神经外科杂志,2016,(12):794.[doi:10.13798/j.issn.1009-153X.2016.12.025]
[8]郑 涛 吕文海 陈 隆 王 元 贺世明 高国栋.经鼻蝶入路内镜下切除垂体腺瘤术后脑脊液漏的治疗[J].中国临床神经外科杂志,2017,(01):46.[doi:10.13798/j.issn.1009-153X.2017.01.018]
[9]吴黎琨,王雪玲,李慧,等.神经导航辅助下经鼻蝶入路切除鞍内型颅咽管瘤的围手术期护理[J].中国临床神经外科杂志,2017,(07):512.[doi:10.13798/j.issn.1009-153X.2017.07.026]
[10]毋江 杨红利 解旭鹏 王甲光.经鼻蝶入路垂体腺瘤切除术后严重颅内感染合并脑积水2例[J].中国临床神经外科杂志,2017,(10):734.[doi:10.13792017.09/j.issn.1009-153X.2017.10.025]

备注/Memo

备注/Memo:
(2022-03-22收稿,2022-05-09修回)
更新日期/Last Update: 2022-07-31